A House subcommittee hearing today exposed partisan divisions over the 340B program’s impact on generic drug shortages. The Sep. 14 [...] …
Year: 2023
The Louisiana attorney general recently asked a federal district judge to dismiss a drug industry lawsuit that challenges Louisiana’s 340B [...] …
California health centers that participate in the 340B program recently appealed a federal district judge’s dismissal of a suit to reverse [...] …
SPONSORED CONTENT
For over 35 years, Avita Care Solutions’ Chief Medical Officer, Dr. Christopher Hall, has devoted his career to democratizing and scaling compassionate and competent care initiatives to underserved communities—the very patients the 340B program was designed to help. In the following interview, he offers
…
An independent cancer care practice is suing a Philadelphia health system in federal court over a range of alleged anti-competitive [...] …
Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...] …
Eligible covered entities in Georgia may enroll in the 340B program immediately, rather than having to wait for the next [...] …
SPONSORED CONTENT
TIP: Keep the complicated operations of your 340B program compliant with the expertise of the Apexus Advanced 340B Operations Certificate Program.
Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...] …
Drug manufacturer Sanofi recently started denying access for some health centers to 340B pricing at contract pharmacies after previously saying [...] …
×
*Sign up for news summaries and alerts from 340B Report